fbpx
QQQ
-0.44
337.55
-0.13%
DIA
-0.30
338.19
-0.09%
SPY
+ 0.21
411.28
+ 0.05%
TLT
-0.06
137.57
-0.04%
GLD
-0.96
164.22
-0.59%

Why Is It Moving? Looking At Gamida Cell's Price Action Today

February 10, 2021 11:06 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Gamida Cell's Stock Price And Volume Action

Gamida Cell's (NASDAQ:GMDA) stock is trading up 23.74% to a price of $13.09. The stock's current volume for the day is 7.05 million, which is approximately 711.58% of its previous 30-day average volume of 990.41 thousand.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Gamida Cell shares are trading higher after the company reported the results of the efficacy and safety for its Phase 3 study of Omidubicel at the TCT meetings of ASTCT and CIBMTR.

Perspective On Recent Price Action

The 50-day moving average price of Gamida Cell's stock was $8.83 when this article was published. The stock reached a high of $11.2 and a low of $2.6 in the past 52 weeks.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

Posted-In:

Movers Trading Ideas

Related Articles

44 Stocks Moving in Thursday's Pre-Market Session

Gainers RCM Technologies, Inc. (NASDAQ: RCMT) shares rose 115.5% to $7.95 in pre-market trading after the company reported its division Thermal Kinetics was awarded Al-Corn Clean Fuels sanitizer-grade ethanol project. read more

94 Biggest Movers From Yesterday

Gainers Anchiano Therapeutics Ltd. (NASDAQ: ANCN) jumped 187.4% to close at $7.96. read more

12 Health Care Stocks Moving In Wednesday's Intraday Session

  read more

70 Stocks Moving In Wednesday's Mid-Day Session

Gainers Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares jumped 244.4% to $17.91 after the company announced it received a third U.S. patent grant related to the manufacture of its platform technology. read more